FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jacques Caen

Research Profile

Anatomy

Chemicals & Drugs

Disorders

Physiology

Co-author Network

Publications

TOP 3
Suzette Béguin; IM Keularts; Raed Al Dieri; Sylvia Bellucci; Jacques Caen; Coenraad Hemker
Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a VWF-GPIb-dependent process, defective in Bernard-Soulier syndrome.
Yanhan Li; Yixin Jin; Huishu Chen; Gu Jie; Gérard Tobelem; Jacques Caen; Zhong Chao Han
Suppression of tumor growth by viral vector-mediated gene transfer of N-terminal truncated platelet factor 4.
Peng Liu; Yi Wang; Yan-Han Li; Chen Yang; Yu-Ling Zhou; Bin Li; Shi-hong Lu; Ren-chi Yang; Ying-lin Cai; Gérard Tobelem; Jacques Caen; Zhong Chao Han
Adenovirus-mediated gene therapy with an antiangiogenic fragment of thrombospondin-1 inhibits human leukemia xenograft growth in nude mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jacques Caen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Suzette Béguin; IM Keularts; Raed Al Dieri; Sylvia Bellucci; Jacques Caen; Coenraad Hemker
Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a VWF-GPIb-dependent process, defective in Bernard-Soulier syndrome.
Journal of thrombosis and haemostasis : JTH 2004;2(1):170-6.
2003: Yanhan Li; Yixin Jin; Huishu Chen; Gu Jie; Gérard Tobelem; Jacques Caen; Zhong Chao Han
Suppression of tumor growth by viral vector-mediated gene transfer of N-terminal truncated platelet factor 4.
Cancer biotherapy & radiopharmaceuticals 2003;18(5):829-40.
2003: Peng Liu; Yi Wang; Yan-Han Li; Chen Yang; Yu-Ling Zhou; Bin Li; Shi-hong Lu; Ren-chi Yang; Ying-lin Cai; Gérard Tobelem; Jacques Caen; Zhong Chao Han
Adenovirus-mediated gene therapy with an antiangiogenic fragment of thrombospondin-1 inhibits human leukemia xenograft growth in nude mice.
Leukemia research 2003;27(8):701-8.
2003: Jacques Caen
[Future anticoagulants appear less dangerous].
Presse médicale (Paris, France : 1983) 2003;32(8):339-40.
2002: Patricia Hainaud; Jean-Philippe Brouland; Patrick André; Guy Simoneau; Claire Bal dit Sollier; Ludovic Drouet; Jacques Caen; Sylvia Bellucci
Dissociation between fibrinogen and fibrin interaction with platelets in patients with different subtypes of Glanzmann's thrombasthenia: studies in an ex vivo perfusion chamber model.
British journal of haematology 2002;119(4):998-1004.
2002: Paquita Nurden; Christel Poujol; Joelle Winckler; Robert Combrié; Jacques Caen; Alan T Nurden
A Ser752-->Pro substitution in the cytoplasmic domain of beta3 in a Glanzmann thrombasthenia variant fails to prevent interactions between the alphaIIbbeta3 integrin and the platelet granule pool of fibrinogen.
British journal of haematology 2002;118(4):1143-51.
2002: Sylvia Bellucci; Jacques Caen
Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment.
Blood reviews 2002;16(3):193-202.
2002: François Lanza; Corinne De La Salle; Marie-Jeanne Baas; Agnès Schwartz; Bernadette Boval; Jean-Pierre Cazenave; Jacques Caen
A Leu7Pro mutation in the signal peptide of platelet glycoprotein (GP)IX in a case of Bernard-Soulier syndrome abolishes surface expression of the GPIb-V-IX complex.
British journal of haematology 2002;118(1):260-6.
2002: Ján Stasko; Ludovic Drouet; Claudine Soria; Elisabeth Mazoyer; Jacques Caen; Peter Kubisz
Erythropoietin and granulocyte colony-stimulating factor increase plasminogen activator inhibitor-1 release in HUVEC culture.
Thrombosis research 2002;105(2):161-4.
2001: P Chen; Chantal Melchior; nicolaas brons; N Schlegel; Jacques Caen; NELLY KIEFFER
Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation.
The Journal of biological chemistry 2001;276(42):38628-35.
2001: Patricia Hainaud; Michel Bonneau; G Pignaud; Claire Bal dit Sollier; Patrick André; P Hadjiisky; J P Fieffé; Jacques Caen; Jean-Marc Herbert; F Dol; Ludovic Drouet
The calcium inhibitor SR33805 reduces intimal formation following injury of the porcine carotid artery.
Atherosclerosis 2001;154(2):301-8.
2000: L Lecomte-Raclet; Mohamed Rholam; M Alemany; Noureddine Lazar; Catherine Simenel; Muriel DELEPIERRE; ZC Han; Paul Cohen; Jacques Caen
Dual structural requirements for multilineage hematopoietic-suppressive activity of chemokine-derived peptides.
Biochemistry 2000;39(31):9612-22.
2000: A M Maurer; Y Liu; Jacques Caen; Zhong Chao Han
Ex vivo expansion of megakaryocytic cells.
International journal of hematology 2000;71(3):203-10.
1999: Jacques Caen; ZC Han; Sylvia Bellucci; M Alemany
Regulation of megakaryocytopoiesis.
Haemostasis 1999;29(1):27-40.
1999: Jouan Hureaux Valerie; Xavier Canron; M Alemany; Jacques Caen; G Quentin; J Plouet; Andreas Bikfalvi
Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action.
Blood 1999;94(3):984-93.
1999: M Lu; J Levin; Eric Sulpice; A Sequeira-Le Grand; M Alemany; Jacques Caen; Z C Han
Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines.
Experimental hematology 1999;27(5):845-52.
1999: Jacques Caen
[The discovery of blood platelets].
La Revue du praticien 1999;49(6):581-2.
1999: Sylvia Bellucci; C Legrand; Bernadette Boval; Ludovic Drouet; Jacques Caen
Studies of platelet volume, chemistry and function in patients with essential thrombocythaemia treated with Anagrelide.
British journal of haematology 1999;104(4):886-92.
1999: M Lozano; Gines Escolar; Sylvia Bellucci; J Monteagudo; M Pico; A Ordinas; Jacques Caen
1-Deamino (8-D-arginine) vasopressin infusion partially corrects platelet deposition on subendothelium in Bernard-Soulier syndrome: the role of factor VIII.
Platelets 1999;10(2-3):141-5.
1998: S Aidoudi; M Guigon; V Drouet; Jacques Caen; ZC Han
The tetrapeptide AcSDKP reduces the sensitivity of murine CFU-MK and CFU-GM progenitors to aracytine in vitro and in vivo.
International journal of hematology 1998;68(2):145-55.
1998: C Perollet; Z C Han; C Savona; Jacques Caen; Andreas Bikfalvi
Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization.
Blood 1998;91(9):3289-99.
1998: L Lecomte-Raclet; M Alemany; A Sequira-Le Grand; Jean Amiral; G Quentin; Anne Marie Vissac; Jacques Caen; ZC Han
New insights into the negative regulation of hematopoiesis by chemokine platelet factor 4 and related peptides.
Blood 1998;91(8):2772-80.
1998: L Lecomte-Raclet; S Aidoudi; I Lebeurier; Claire Bal dit Sollier; G Kishtoo; J F Aubert; Jacques Caen; ZC Han
Quantitation of megakaryocytopoiesis by computerized automatic in culture image analysis.
Platelets 1998;9(2):121-7.
1998: Jacques Caen; Sylvia Bellucci
[Constitutional thrombopathies: from the clinical description of rare diseases (Glanzmann thrombasthenia and Bernard-Soulier syndrome) to the development of new antithrombotic agents].
Bulletin de l'Académie nationale de médecine 1998;182(7):1493-502; discussion 1502-3.
1998: A M Maurer; Jacques Caen; Z C Han
[Chemokines and the regulation of hematopoiesis].
Comptes rendus des séances de la Société de biologie et de ses filiales 1998;192(5):917-23.
1997: S Aïdoudi; I Lebeurier; Jean Amiral; G Quentin; Jacques Caen; ZC Han
A 13-24 C-terminal peptide related to PF4 accelerates hematopoietic recovery of progenitor cells in vivo in mice treated with 5-fluorouracil.
International journal of hematology 1997;66(4):435-44.
1997: F Nadal; Sylviane Lévy-Toledano; F Grelac; Jacques Caen; Jean-Philippe Rosa; Marijke Bryckaert
Negative regulation of mitogen-activated protein kinase activation by integrin alphaIIbbeta3 in platelets.
The Journal of biological chemistry 1997;272(36):22381-4.
1997: Yves Gruel; Gérard Pacouret; Sylvia Bellucci; Jacques Caen
Severe proximal deep vein thrombosis in a Glanzmann thrombasthenia variant successfully treated with a low molecular weight heparin.
Blood 1997;90(2):888-90.
1997: Jean-Philippe Rosa; V Artçanuthurry; F Grelac; Jacques Maclouf; Jacques Caen; Sylviane Lévy-Toledano
Reassessment of protein tyrosine phosphorylation in thrombasthenic platelets: evidence that phosphorylation of cortactin and a 64-kD protein is dependent on thrombin activation and integrin alphaIIb beta3.
Blood 1997;89(12):4385-92.
1997: Sylvia Bellucci; Jacques Caen
Gastrointestinal angiodysplasia in constitutional thrombocytopathies.
International journal of hematology 1997;65(4):419-20.
1997: Patrick André; Patricia Hainaud; Claire Bal dit Sollier; L I Garfinkel; Jacques Caen; Ludovic Drouet
Relative involvement of GPIb/IX-vWF axis and GPIIb/IIIa in thrombus growth at high shear rates in the guinea pig.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(5):919-24.
1997: Z C Han; M Lu; J Li; M Defard; Bernadette Boval; N Schlegel; Jacques Caen
Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents.
Blood 1997;89(7):2328-35.
1997: Sylvia Bellucci; J P Girma; M Lozano; D Meyer; Jacques Caen
Impaired prothrombin consumption in Bernard-Soulier syndrome is corrected in vitro by human factor VIII.
Thrombosis and haemostasis 1997;77(2):383-6.
1997: Y Z Chen; F Incardona; C Legrand; L Momeux; Jacques Caen; Z C Han
Thrombospondin, a negative modulator of megakaryocytopoiesis.
The Journal of laboratory and clinical medicine 1997;129(2):231-8.
1997: Sylvia Bellucci; ZC Han; Jacques Caen
[Effects of heparin on megakaryocytopoiesis. From fundamental data to clinical applications].
Annales de médecine interne 1997;148(2):150-3.
1997: R Y Li; Frédérique Gaits; Jeannie Ragab-Thomas; Jacques Maclouf; Jacques Caen; Sylviane Lévy-Toledano; Hugues Chap
Protein tyrosine phosphatase SHP-1 fails to associate with cytoskeleton but is normally phosphorylated upon thrombin stimulation of thrombasthenic platelets.
Thrombosis and haemostasis 1997;77(1):150-4.
1997: Sylvia Bellucci; Z C Han; Jacques Caen
Therapy of chronic autoimmune purpura (ITP)
British journal of haematology 1997;96(1):212-3.
1996: S Aidoudi; M Guigon; I Lebeurier; Jacques Caen; ZC Han
In vivo effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP on haemopoiesis of mice treated with 5-fluorouracil.
British journal of haematology 1996;94(3):443-8.
1996: Patrick André; P Hamaud; Claire Bal dit Sollier; V Drouet; L I Garfinkel; A Uzan; Jacques Caen; Ludovic Drouet
Guinea pig blood: a model for the pharmacologic modulation of the GPIb/IX-vWF axis.
Thrombosis research 1996;83(2):127-36.
1996: ZC Han; Sylvia Bellucci; Z X Shen; J P Maffrand; M Pascal; Maurice Petitou; JC Lormeau; Jacques Caen
Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulators.
Journal of cellular physiology 1996;168(1):97-104.
1996: X Xi; Jacques Caen; S Fournier; N Schlegel; Jean Amiral; O Sibony; P Blot; ZC Han
Direct and reversible inhibition of platelet factor 4 on megakaryocyte development from CD34+ cord blood cells: comparative studies with transforming growth factor beta1.
British journal of haematology 1996;93(2):265-72.
1996: Claire Bal dit Sollier; Ludovic Drouet; G Pignaud; C Chevallier; Jacques Caen; A M Fiat; C Izquierdo; P Jolles
Effect of kappa-casein split peptides on platelet aggregation and on thrombus formation in the guinea-pig.
Thrombosis research 1996;81(4):427-37.
1996: I Lebeurier; L Raclet; Jean Amiral; Jacques Caen; ZC Han
Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell lines.
The Journal of laboratory and clinical medicine 1996;127(2):179-85.
1996: I Lebeurier; N Basara; S Aïdoudi; Jean Amiral; Jacques Caen; ZC Han
Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin.
British journal of haematology 1996;92(1):29-34.
1996: Patrick André; B Arbeille; V Drouet; Patricia Hainaud; Claire Bal dit Sollier; Jacques Caen; Ludovic Drouet
Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth. An ex vivo capillary perfusion chamber study in the guinea pig.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(1):56-63.
1995: Jacques Caen; X Xi; S Aidoudi; S Fournier; N Schlegel; Sylvia Bellucci; ZC Han
[Platelet factor 4, reversible inhibitor of megakaryocytogenesis, protector of megakaryocytes during chemotherapy].
Bulletin de l'Académie nationale de médecine 1995;179(8):1657-70.
1995: X F Gu; Andreas Bikfalvi; Y Z Chen; Jacques Caen; ZC Han
Constitutive and selective expression of basic fibroblast growth factor in human leukaemia cell lines.
European journal of haematology 1995;55(3):189-94.
1995: X Xi; N Schlegel; Jacques Caen; A Minty; S Fournier; D Caput; Pascual Ferrara; ZC Han
Differential effects of recombinant human interleukin-13 on the in vitro growth of human haemopoietic progenitor cells.
British journal of haematology 1995;90(4):921-7.
1995: Z X Shen; J M Li; Z Y Wang; ZC Han; Jacques Caen; Sylvia Bellucci
Thrombocytopoietic effect of heparin given in chronic immune thrombocytopenic purpura.
Lancet 1995;346(8969):220-1.
1995: Jacques Caen; Jean-Philippe Rosa
Platelet-vessel wall interaction: from the bedside to molecules.
Thrombosis and haemostasis 1995;74(1):18-24.
1995: Sylviane Lévy-Toledano; F Grelac; Jacques Caen; Jacques Maclouf
KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
Thrombosis and haemostasis 1995;73(5):857-61.
1995: Elisabeth Mazoyer; Jacques Caen; D Tenza; Elisabeth M Cramer
The Anti-aggregating Peptide KRDS Impairs a-granule Release, Whereas RGDS Does Not.
Platelets 1995;6(2):91-8.
1994: Z X Shen; N Basara; X D Xi; Jacques Caen; J P Maffrand; M Pascal; Maurice Petitou; JC Lormeau; ZC Han
Fraxiparin, a low-molecular-weight heparin, stimulates megakaryocytopoiesis in vitro and in vivo in mice.
British journal of haematology 1994;88(3):608-12.
1994: Y Z Chen; X F Gu; Jacques Caen; ZC Han
Interleukin-3 is an autocrine growth factor of human megakaryoblasts, the DAMI and MEG-01 cells.
British journal of haematology 1994;88(3):481-7.
1993: I Djaffar; Jacques Caen; Jean-Philippe Rosa
A large alteration in the human platelet glycoprotein IIIa (integrin beta 3) gene associated with Glanzmann's thrombasthenia.
Human molecular genetics 1993;2(12):2183-5.
1993: X F Gu; A Allain; L Li; Elisabeth M Cramer; D Tenza; Jacques Caen; ZC Han
[Expression of cyclin B in megakaryocytes and cells of other hematopoietic lines].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1993;316(12):1438-45.
1993: He Lu; Claudine Soria; J Soria; christophe de romeuf; J Y Perrot; D Tenza; I Garcia; Jacques Caen; Elisabeth M Cramer
Reversible translocation of glycoprotein Ib in plasmin-treated platelets: consequences for platelet function.
European journal of clinical investigation 1993;23(12):785-93.
1993: Elisabeth M Cramer; J M Massé; Jacques Caen; I Garcia; J Breton-Gorius; Najet Debili; W Vainchenker
Effect of thrombin on maturing human megakaryocytes.
The American journal of pathology 1993;143(5):1498-508.
1993: Jacques Caen; J Soria; J P Collet; C Soria
[Fibrinogen, a vascular risk factor].
Bulletin de l'Académie nationale de médecine 1993;177(8):1433-41; discussion 1441-4.
1993: Françoise Fauvel-Lafève; V Tabaka; Jacques Caen; Y Legrand
Defective adhesion of blood platelets to vascular microfibrils in the Bernard-Soulier syndrome.
Blood 1993;82(7):1985-8.
1993: Jacques Caen; ZC Han
Control of megakaryocyte development: from basic data to clinical results.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1993;316(9):919-30.
1993: ZC Han; Jacques Caen
Are megakaryocytes and endothelial cells sisters?
The Journal of laboratory and clinical medicine 1993;121(6):821-5.
1993: A M Fiat; D Migliore-Samour; P Jollès; Ludovic Drouet; Claire Bal dit Sollier; Jacques Caen
Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities.
Journal of dairy science 1993;76(1):301-10.
1992: Charles Marc Samama; P Bonnin; Michel Bonneau; G Pignaud; Elisabeth Mazoyer; Olivier Bailliart; J P Maffrand; P Viars; Jacques Caen; Ludovic Drouet
Comparative arterial antithrombotic activity of clopidogrel and acetyl salicylic acid in the pig.
Thrombosis and haemostasis 1992;68(5):500-5.
1992: Y P Chen; I Djaffar; Dominique Pidard; B Steiner; A M Cieutat; Jacques Caen; Jean-Philippe Rosa
Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(21):10169-73.
1992: ZC Han; A M Maurer; Sylvia Bellucci; H Y Wan; Y Kroviarski; O Bertrand; Jacques Caen
Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4.
The Journal of laboratory and clinical medicine 1992;120(4):645-60.
1992: Sylvia Bellucci; ZC Han; Dominique Pidard; Jacques Caen
Identification of a normal human bone marrow cell population co-expressing megakaryocytic and erythroid markers in culture.
European journal of haematology 1992;48(5):259-65.
1992: ZC Han; Sylvia Bellucci; H Y Wan; Jacques Caen
New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblastic growth factors and transforming growth factor beta 1.
British journal of haematology 1992;81(1):1-5.
1992: B Boizard-Boval; Jean-Luc Wautier; Y Gruel; Jacques Caen
Immunological study of platelet glycoproteins and alloantigens in families of patients with Glanzmann's thrombasthenia.
Nouvelle revue française d'hématologie 1992;34(1):93-8.
1992: Sylvia Bellucci; Jacques Caen
[Platelets and aging].
Comptes rendus des séances de la Société de biologie et de ses filiales 1992;186(3):193-7.
1991: H Lu; C Soria; P L Commin; J Soria; A Piwnica; F Schumann; O Regnier; Y Legrand; Jacques Caen
Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol).
Thrombosis and haemostasis 1991;66(6):633-7.
1991: Jacques Caen; Elisabeth M Cramer; Francine Rendu; M Bryckaert; E Dupuy; Sylviane Levy-Toledano
[Gray platelet syndrome, an example of myelofibrosis of megakaryocytic origin].
Bulletin de l'Académie nationale de médecine 1991;175(7):1145-52; discussion 1152-3.
1991: J F Deschamps; E Bodevin; E Savariau; Jocelyne Enouf; A M Lompre; C Dosquet; Jacques Caen
Immunocytochemical study of a Ca(2+)-ATPase enzyme in the human megakaryocytic lineage.
Experimental hematology 1991;19(8):729-33.
1991: Charles Marc Samama; Michel Bonneau; Olivier Bailliart; G Pignaud; M L Scrobohaci; Jacques Caen; P Viars; Ludovic Drouet
Absence of side effects of hydroxyethylstarch 200 in a porcine model of experimental arterial thrombosis.
Thrombosis research 1991;62(5):591-8.
1991: Elisabeth Mazoyer; B Boizard-Boval; Dominique Pidard; Jacques Caen; Jean-Luc Wautier
Platelet membrane glycoproteins and platelet functions during storage in the presence of a proteinase inhibitor.
Thrombosis research 1991;62(3):165-75.
1991: Elisabeth M Cramer; He Lu; Jacques Caen; Claudine Soria; M C Berndt; D Tenza
Differential redistribution of platelet glycoproteins Ib and IIb-IIIa after plasmin stimulation.
Blood 1991;77(4):694-9.
1991: ZC Han; Sylvia Bellucci; Jacques Caen
Megakaryocytopoiesis: characterization and regulation in normal and pathologic states.
International journal of hematology 1991;54(1):3-14.
1991: H Lu; C Soria; H Li; J Soria; H R Lijnen; J Y Perrot; Jacques Caen
Role of active center and lysine binding sites of plasmin in plasmin-induced platelet activation and disaggregation.
Thrombosis and haemostasis 1991;65(1):67-72.
1991: A Darnanville; Raymonde Bredoux; K J Clemetson; NELLY KIEFFER; N Bourdeau; Sylviane Levy-Toledano; Jacques Caen; Jocelyne Enouf
The phosphoprotein that regulates platelet Ca2+ transport is located on the plasma membrane, controls membrane-associated Ca2(+)-ATPase and is not glycoprotein Ib beta-subunit.
The Biochemical journal 1991;273(Pt 2)():429-34.
1991: C Legrand; France Woimant; Michel Haguenau; Jacques Caen
Platelet surface glycoprotein changes in patients with cerebral ischemia.
Nouvelle revue française d'hématologie 1991;33(6):497-9.
1991: Sylvia Bellucci; C Dosquet; Bernadette Boval; Jean-Luc Wautier; Jacques Caen
Association of autoimmune thrombocytopenic purpura (AITP), Graves' disease and ovarian carcinoma.
Nouvelle revue française d'hématologie 1991;33(4):307-9.
1991: ZC Han; Sylvia Bellucci; E Bodevin; H Y Wan; Z X Shen; Jacques Caen
In vivo inhibition of megakaryocyte and platelet production by platelet factor 4 in mice.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1991;313(12):553-8.
1991: Jacques Caen; ZC Han; Sylvia Bellucci
Growth and differentiation factors in megakaryocytopoiesis.
Nouvelle revue française d'hématologie 1991;33(2):165-7.
1990: Elisabeth Mazoyer; S Lévy-Toledano; F Rendu; L Hermant; He Lu; A M Fiat; P Jollès; Jacques Caen
KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
European journal of biochemistry / FEBS 1990;194(1):43-9.
1990: Sylvia Bellucci; A Kedra; P Bray; Jacques Caen
Platelet aggregation is not necessary for occurrence of Raynaud's phenomenon: a clinical history and laboratory results.
Angiology 1990;41(11):970-2.
1990: ZC Han; Sylvia Bellucci; A Walz; M Baggiolini; Jacques Caen
Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue-activating peptide (CTAP-III).
International journal of cell cloning 1990;8(4):253-9.
1990: P Herve; Ludovic Drouet; C Dosquet; J M Launay; B Rain; G Simonneau; Jacques Caen; P Duroux
Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin.
The American journal of medicine 1990;89(1):117-20.
1990: J N George; Jacques Caen; A T Nurden
Glanzmann's thrombasthenia: the spectrum of clinical disease.
Blood 1990;75(7):1383-95.
1990: ZC Han; Sylvia Bellucci; D Tenza; Jacques Caen
Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura.
British journal of haematology 1990;74(4):395-401.
1990: Elisabeth M Cramer; G F Savidge; W Vainchenker; M C Berndt; Dominique Pidard; Jacques Caen; J M Massé; J Breton-Gorius
Alpha-granule pool of glycoprotein IIb-IIIa in normal and pathologic platelets and megakaryocytes.
Blood 1990;75(6):1220-7.
1990: Ludovic Drouet; Claire Bal dit Sollier; M Cisse; G Pignaud; Elisabeth Mazoyer; A M Fiat; P Jolles; Jacques Caen
The antithrombotic effect of KRDS, a lactotransferrin peptide, compared with RGDS.
Nouvelle revue française d'hématologie 1990;32(1):59-62.
1990: Claire Bal dit Sollier; Ludovic Drouet; A M Fiat; P Jolles; Jacques Caen
[Anti-thrombotic effect of lacto-transferrin peptides].
Comptes rendus des séances de la Société de biologie et de ses filiales 1990;184(3-4):201-10.
1990: M Mirshahi; J Soria; C Soria; M Samama; Jacques Caen
Degradation of fibrinogen by tissue plasminogen activator. Consequences for fibrin polymerization.
Thrombosis research. Supplement 1990;10():21-6.
1990: ZC Han; Sylvia Bellucci; Jacques Caen
Regulation of human megakaryocytopoiesis.
Nouvelle revue française d'hématologie 1990;32(6):395-6.
1989: M Mirshahi; J Soria; C Soria; R Faivre; H Lu; M Courtney; C Roitsch; D Tripier; Jacques Caen
Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis.
Blood 1989;74(3):1025-30.
1989: D Pintigny; Jean-Luc Wautier; Marie-Paule Wautier; Jacques Caen
Modification of membrane properties of erythrocytes by PGI2.
Thrombosis research 1989;54(6):643-53.
1989: Ludovic Drouet; Jacques Caen
Current perspectives in the treatment of thrombotic disorders.
Seminars in thrombosis and hemostasis 1989;15(2):111-22.
1989: P J Guillausseau; E Dupuy; M C Bryckaert; J Timsit; P Chanson; Gérard Tobelem; Jacques Caen; J Lubetzki
Platelet-derived growth factor (PDGF) in type 1 diabetes mellitus.
European journal of clinical investigation 1989;19(2):172-5.
1989: J Carvalho de Sousa; Eric Bruckert; Philippe Giral; C Soria; J Chapman; J Truffert; F Dairou; Jean Luc de Gennes; Jacques Caen
Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity.
Haemostasis 1989;19(3):125-30.
1989: J Carvalho de Sousa; Eric Bruckert; Philippe Giral; C Soria; J Truffert; M C Mirshahi; Jean Luc de Gennes; Jacques Caen
Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.
Haemostasis 1989;19(2):83-90.
1988: Ludovic Drouet; Bruno Baudin; F C Baumann; Jacques Caen
Serum angiotensin-converting enzyme: an endothelial cell marker. Application to thromboembolic pathology.
The Journal of laboratory and clinical medicine 1988;112(4):450-7.
1988: J C de Sousa; C Soria; M Ayrault-Jarrier; D Pastier; Eric Bruckert; J Amiral; G Bereziat; Jacques Caen
Association between coagulation factors VII and X with triglyceride rich lipoproteins.
Journal of clinical pathology 1988;41(9):940-4.
1988: R Cariou; Gérard Tobelem; Sylvia Bellucci; J Soria; C Soria; Jacques Maclouf; Jacques Caen
Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation.
Thrombosis and haemostasis 1988;60(1):54-8.
1988: J Carvalho de Sousa; J Azevedo; C Soria; F Barros; C Ribeiro; F Parreira; Jacques Caen
Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation.
Thrombosis research 1988;51(2):165-73.
1988: S Raha; C Dosquet; J F Abgrall; P Jolles; A M Fiat; Jacques Caen
KRDS--a tetrapeptide derived from lactotransferrin--inhibits binding of monoclonal antibody against glycoprotein IIb-IIIa on ADP-stimulated platelets and megakaryocytes.
Blood 1988;72(1):172-8.
1988: Jacques Caen
A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. A French multicenter trial.
Thrombosis and haemostasis 1988;59(2):216-20.
1988: S Bellucci; Jacques Caen
Congenital platelet disorders.
Blood reviews 1988;2(1):16-26.
1988: F Pontet; X Gué; C Dosquet; Jacques Caen; F Rousselet
Rapid evolution in the immunochemical findings of a gamma heavy chain disease.
Clinical chemistry 1988;34(2):439-43.
1988: Sylvia Bellucci; W Kedra; N Ajzenberg; Gérard Tobelem; Jacques Caen
[New treatments for Raynaud's syndrome].
Nouvelle revue française d'hématologie 1988;30(1-2):103-7.
1988: M J Grange; C Cywiner-Golenzer; Jacques Caen
Granulocytic sarcoma of the small intestine: a case report.
Nouvelle revue française d'hématologie 1988;30(4):251-3.
1988: H Lu; M Mirshahi; C Soria; J Soria; H Li; C Dosquet-Bernard; Jacques Caen
Enhanced expression of urokinase activity on U 937 cell line by 1,25-dihydroxyvitamin D3 induction.
Thrombosis research. Supplement 1988;8():57-63.
1987: Francine Rendu; P Marche; T Hovig; Jacques Maclouf; Marilyne Lebret; D Tenza; Sylviane Levy-Toledano; Jacques Caen
Abnormal phosphoinositide metabolism and protein phosphorylation in platelets from a patient with the grey platelet syndrome.
British journal of haematology 1987;67(2):199-206.
1987: T Barzu; J L van Rijn; Maurice Petitou; Gérard Tobelem; Jacques Caen
Heparin degradation in the endothelial cells.
Thrombosis research 1987;47(5):601-9.
1987: S Bellucci; A W Kedra; V Naccache-Herman; E Cambau; G Tobelem; Jacques Caen
[Treatment of Raynaud's syndrome with ketanserin. Clinical, biological and hemodynamic aspects].
Presse médicale (Paris, France : 1983) 1987;16(27):1335.
1987: Francine Rendu; P Marche; J Viret; Jacques Maclouf; Marilyne Lebret; D Tenza; Jacques Caen; Sylviane Levy-Toledano
Signal transduction in normal and pathological thrombin-stimulated human platelets.
Biochimie 1987;69(4):305-13.
1987: J L van Rijn; M Trillou; J Mardiguian; Gérard Tobelem; Jacques Caen
Selective binding of heparins to human endothelial cells. Implications for pharmacokinetics.
Thrombosis research 1987;45(3):211-22.
1987: Jacques Caen; J F Deschamps; E Bodevin; M C Bryckaert; E Dupuy; A Wasteson
Megakaryocytes and myelofibrosis in gray platelet syndrome.
Nouvelle revue française d'hématologie 1987;29(2):109-14.
1986: P Jollès; S Lévy-Toledano; A M Fiat; C Soria; D Gillessen; A Thomaidis; F W Dunn; Jacques Caen
Analogy between fibrinogen and casein. Effect of an undecapeptide isolated from kappa-casein on platelet function.
European journal of biochemistry / FEBS 1986;158(2):379-82.
1986: R Cariou; Gérard Tobelem; C Soria; Jacques Caen
Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant.
The New England journal of medicine 1986;314(18):1193-4.
1986: Jean-Luc Wautier; H LeBlanc; Marie-Paule Wautier; E Abadie; P Passa; Jacques Caen
Erythrocyte adhesion to cultured endothelium and glycaemic control in type 1 (insulin-dependent) diabetic patients.
Diabetologia 1986;29(3):151-5.
1986: S Bellucci; A W Kedra; J M Courmelle; J Maclouf; B Boizard; C Dosquet-Bernard; G Tobelem; Jacques Caen
Prolonged remission in Raynaud's phenomenon after prostacyclin infusion.
Scandinavian journal of rheumatology 1986;15(4):392-8.
1986: R Cariou; Gérard Tobelem; Jacques Caen
[Circulating lupus-type anticoagulant, a risk factor for thrombosis by inhibition of protein C activation].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1986;303(4):113-8.
1985: Jean-Luc Wautier; F Galacteros; Marie-Paule Wautier; D Pintigny; Y Beuzard; J Rosa; Jacques Caen
Clinical manifestations and erythrocyte adhesion to endothelium in sickle cell syndrome.
American journal of hematology 1985;19(2):121-30.
1985: Francine Rendu; P Marche; J Viret; D Daveloose; F Leterrier; Sylviane Levy-Toledano; Jacques Caen
Molecular membrane organization in normal and pathological platelets: changes in inositide metabolism and membrane fluidity.
Nouvelle revue française d'hématologie 1985;27(4):293-7.
1984: Jean-Luc Wautier; Marie-Paule Wautier; C Guillam-Megnin; D Pintigny; F Galacteros; P Passa; J Bescol-Liversac; Jacques Caen
[Endothelial cells and adhesion of red cells in diabetes and sickle cell anemia. Quantitative and qualitative aspects].
Nouvelle revue française d'hématologie 1984;26(6):379-85.
1984: F W Dunn; J Soria; C Soria; A Thomaidis; H Lee; Jacques Caen
In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets.
Agents and actions. Supplements 1984;15():97-104.
1983: Jean-Luc Wautier; D Pintigny; Marie-Paule Wautier; R C Paton; F Galacteros; P Passa; Jacques Caen
Fibrinogen, a modulator of erythrocyte adhesion to vascular endothelium.
The Journal of laboratory and clinical medicine 1983;101(6):911-20.
1983: Jean-Luc Wautier; Marie-Paule Wautier; D Pintigny; F Galacteros; A Courillon; P Passa; Jacques Caen
Factors involved in cell adhesion to vascular endothelium.
Blood cells 1983;9(2):221-34.
1982: Jean-Luc Wautier; Marie-Paule Wautier; D Pintigny; C Paton; E Abadie; P Passa; Jacques Caen
[Cellular aspects of thrombosis in the diabetic].
Nouvelle revue française d'hématologie 1982;24(3):183-6.
1981: Jean-Luc Wautier; R C Paton; Marie-Paule Wautier; D Pintigny; E Abadie; P Passa; Jacques Caen
Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications.
The New England journal of medicine 1981;305(5):237-42.